Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 8 | 2018 | 471 | 1.090 |
Why?
|
| Fatty Acids | 5 | 2018 | 98 | 0.980 |
Why?
|
| Neoplasms | 6 | 2013 | 728 | 0.940 |
Why?
|
| Lipogenesis | 2 | 2012 | 18 | 0.810 |
Why?
|
| NAD | 2 | 2018 | 27 | 0.740 |
Why?
|
| Antineoplastic Agents | 5 | 2008 | 608 | 0.680 |
Why?
|
| Enzyme Inhibitors | 6 | 2016 | 166 | 0.680 |
Why?
|
| Lactones | 5 | 2017 | 10 | 0.660 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 101 | 0.610 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2018 | 13 | 0.580 |
Why?
|
| Cytokines | 2 | 2018 | 256 | 0.510 |
Why?
|
| Cell Line, Tumor | 9 | 2018 | 726 | 0.470 |
Why?
|
| Apoptosis | 7 | 2017 | 360 | 0.460 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 1 | 0.410 |
Why?
|
| Endoplasmic Reticulum | 3 | 2016 | 24 | 0.400 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2012 | 23 | 0.400 |
Why?
|
| Cell Movement | 1 | 2012 | 169 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 19 | 0.320 |
Why?
|
| Protein Kinases | 2 | 2018 | 26 | 0.310 |
Why?
|
| Signal Transduction | 9 | 2016 | 682 | 0.310 |
Why?
|
| Humans | 30 | 2018 | 32114 | 0.310 |
Why?
|
| Peptide Library | 2 | 2011 | 6 | 0.300 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2002 | 30 | 0.290 |
Why?
|
| Antithrombin III | 2 | 1997 | 4 | 0.290 |
Why?
|
| Oligosaccharides | 2 | 1997 | 4 | 0.290 |
Why?
|
| Heparin | 2 | 1997 | 73 | 0.270 |
Why?
|
| Animals | 15 | 2017 | 7542 | 0.270 |
Why?
|
| Nanoparticles | 2 | 2017 | 52 | 0.270 |
Why?
|
| Cell Proliferation | 5 | 2018 | 604 | 0.250 |
Why?
|
| Mice | 9 | 2016 | 2484 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2001 | 153 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 171 | 0.210 |
Why?
|
| Hydrolysis | 6 | 2015 | 35 | 0.210 |
Why?
|
| Metalloendopeptidases | 1 | 2002 | 11 | 0.210 |
Why?
|
| Male | 11 | 2018 | 19217 | 0.210 |
Why?
|
| Transfection | 3 | 2018 | 191 | 0.200 |
Why?
|
| Mitochondria | 3 | 2018 | 187 | 0.200 |
Why?
|
| Models, Molecular | 4 | 2015 | 193 | 0.200 |
Why?
|
| Bacteriophages | 1 | 2001 | 2 | 0.200 |
Why?
|
| Endopeptidases | 1 | 2001 | 26 | 0.190 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 765 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 261 | 0.190 |
Why?
|
| Lipids | 2 | 2018 | 232 | 0.170 |
Why?
|
| Peptides | 3 | 2016 | 120 | 0.170 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 163 | 0.170 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 147 | 0.160 |
Why?
|
| Acrylamides | 1 | 2018 | 4 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2008 | 181 | 0.160 |
Why?
|
| Tretinoin | 1 | 2018 | 34 | 0.160 |
Why?
|
| Cell Death | 2 | 2008 | 77 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2017 | 256 | 0.150 |
Why?
|
| Enzyme Activation | 3 | 2012 | 135 | 0.150 |
Why?
|
| Tubulin Modulators | 1 | 2017 | 10 | 0.150 |
Why?
|
| Piperidines | 1 | 2018 | 118 | 0.150 |
Why?
|
| Microtubules | 1 | 2017 | 23 | 0.150 |
Why?
|
| Lysine | 1 | 1997 | 23 | 0.140 |
Why?
|
| Homeostasis | 1 | 2017 | 132 | 0.140 |
Why?
|
| Taxoids | 1 | 2017 | 59 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 66 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2017 | 100 | 0.140 |
Why?
|
| Gene Expression | 1 | 2018 | 338 | 0.140 |
Why?
|
| Substrate Specificity | 4 | 2015 | 87 | 0.140 |
Why?
|
| Thrombin | 1 | 1996 | 16 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 104 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 19 | 0.130 |
Why?
|
| YY1 Transcription Factor | 1 | 2016 | 6 | 0.130 |
Why?
|
| Acyl Coenzyme A | 1 | 2015 | 5 | 0.130 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 7 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 18 | 0.130 |
Why?
|
| Cell Survival | 2 | 2017 | 285 | 0.130 |
Why?
|
| Kinetics | 4 | 2002 | 209 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 70 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2015 | 247 | 0.120 |
Why?
|
| Binding Sites | 4 | 2016 | 130 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2016 | 180 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 35 | 0.120 |
Why?
|
| Lactation | 1 | 2014 | 16 | 0.120 |
Why?
|
| Milk | 1 | 2014 | 16 | 0.120 |
Why?
|
| Esterases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Adiposity | 1 | 2015 | 198 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 114 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 33 | 0.110 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 65 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2011 | 638 | 0.110 |
Why?
|
| Acetic Acid | 1 | 2013 | 1 | 0.110 |
Why?
|
| Carbon Isotopes | 1 | 2013 | 9 | 0.110 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 359 | 0.110 |
Why?
|
| Adenylate Kinase | 1 | 2012 | 3 | 0.110 |
Why?
|
| Phospholipids | 1 | 2012 | 28 | 0.100 |
Why?
|
| Sirtuins | 1 | 2012 | 20 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2002 | 14 | 0.100 |
Why?
|
| Genes, src | 1 | 2012 | 1 | 0.100 |
Why?
|
| 3T3 Cells | 1 | 2012 | 14 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2016 | 229 | 0.100 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 108 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 48 | 0.100 |
Why?
|
| Models, Biological | 2 | 2016 | 392 | 0.100 |
Why?
|
| Base Sequence | 3 | 2006 | 252 | 0.100 |
Why?
|
| Mice, Nude | 3 | 2011 | 291 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 190 | 0.090 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2008 | 2 | 0.090 |
Why?
|
| Thapsigargin | 2 | 2008 | 8 | 0.090 |
Why?
|
| HT29 Cells | 2 | 2007 | 4 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2011 | 156 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 633 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2015 | 65 | 0.080 |
Why?
|
| Hispanic Americans | 1 | 2015 | 940 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2008 | 11 | 0.080 |
Why?
|
| DNA Primers | 2 | 2001 | 91 | 0.080 |
Why?
|
| Boronic Acids | 1 | 2008 | 8 | 0.080 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2008 | 15 | 0.080 |
Why?
|
| Pyrazines | 1 | 2008 | 13 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 25 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 14 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2008 | 55 | 0.080 |
Why?
|
| Glioma | 2 | 2007 | 136 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 55 | 0.080 |
Why?
|
| Female | 7 | 2016 | 20015 | 0.080 |
Why?
|
| Acetates | 1 | 2008 | 10 | 0.080 |
Why?
|
| Carbon | 1 | 2008 | 12 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2008 | 12 | 0.080 |
Why?
|
| Propiophenones | 1 | 2007 | 4 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 1176 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2007 | 15 | 0.070 |
Why?
|
| Drug Design | 1 | 2007 | 43 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2008 | 77 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 69 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 189 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2007 | 1 | 0.070 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 3 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2007 | 110 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2017 | 443 | 0.070 |
Why?
|
| eIF-2 Kinase | 1 | 2007 | 6 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 13 | 0.070 |
Why?
|
| Hela Cells | 1 | 2007 | 79 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 78 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 75 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 80 | 0.070 |
Why?
|
| Protein Binding | 2 | 2016 | 201 | 0.070 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 105 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 99 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 285 | 0.060 |
Why?
|
| Phenylmercuric Acetate | 1 | 2002 | 4 | 0.050 |
Why?
|
| S-Nitrosothiols | 1 | 2002 | 5 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 2011 | 268 | 0.050 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2002 | 1 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 90 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 138 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 126 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 70 | 0.050 |
Why?
|
| Catalysis | 1 | 2001 | 65 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2002 | 146 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2015 | 27 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2011 | 115 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 951 | 0.040 |
Why?
|
| Neurons | 1 | 2002 | 410 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2017 | 35 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2017 | 9 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 25 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 66 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1997 | 33 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 24 | 0.040 |
Why?
|
| Threonine | 1 | 1996 | 9 | 0.040 |
Why?
|
| Glutamine | 1 | 1996 | 9 | 0.030 |
Why?
|
| Lipoylation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 62 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 8 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 80 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 74 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 142 | 0.030 |
Why?
|
| Fatty Acid Synthesis Inhibitors | 1 | 2016 | 3 | 0.030 |
Why?
|
| Acyl Carrier Protein | 1 | 2015 | 3 | 0.030 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2015 | 9 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 12 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2015 | 20 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2015 | 41 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2015 | 19 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2016 | 36 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2015 | 84 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 146 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 469 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 114 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 399 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 835 | 0.030 |
Why?
|
| Receptors, Prostaglandin | 1 | 2011 | 3 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2011 | 31 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 26 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2011 | 33 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 1062 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 82 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 2151 | 0.020 |
Why?
|
| Rats | 2 | 2006 | 1596 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 29 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 41 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 53 | 0.020 |
Why?
|
| Autophagy | 1 | 2008 | 52 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2008 | 17 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2007 | 2 | 0.020 |
Why?
|
| Racemases and Epimerases | 1 | 2007 | 4 | 0.020 |
Why?
|
| Phytanic Acid | 1 | 2007 | 4 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 61 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 4 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 4 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 81 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2007 | 46 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 17 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2007 | 36 | 0.020 |
Why?
|
| Zebrafish | 1 | 2007 | 23 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 99 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 93 | 0.020 |
Why?
|
| DNA Repair | 1 | 2007 | 64 | 0.020 |
Why?
|
| Collagen Type XI | 1 | 2006 | 1 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 148 | 0.020 |
Why?
|
| Cerulenin | 1 | 2006 | 3 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 34 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2006 | 24 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 322 | 0.020 |
Why?
|
| Astrocytes | 1 | 2006 | 58 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 220 | 0.020 |
Why?
|
| Vitamin D | 1 | 2007 | 184 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2006 | 185 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 560 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 289 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 215 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 308 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 414 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 2 | 0.010 |
Why?
|
| Reperfusion | 1 | 2002 | 21 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 17 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 35 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2002 | 111 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 435 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 834 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 767 | 0.010 |
Why?
|